About us

NILO Therapeutics is an early-stage biotech company developing groundbreaking therapies for autoimmune and inflammatory diseases. Our experienced team brings together diverse interdisciplinary expertise to modulate immune responses via activation of neural circuits. United by our passion for discovering and translating novel biology, we are dedicated to advancing human health through transformative science.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
New York City
Type
Privately Held

Locations

Employees at Nilo Therapeutics

Similar pages

Funding

Nilo Therapeutics 2 total rounds

Last Round

Series unknown

US$ 9.6M

See more info on crunchbase